Agency Forms Undergoing Paperwork Reduction Act Review, 77396-77397 [E5-8098]
Download as PDF
77396
Federal Register / Vol. 70, No. 250 / Friday, December 30, 2005 / Notices
Commission by January 13, 2006 (see
FOR FURTHER INFORMATION CONTACT).
ADDRESSES: The Meeting: The meeting
will be held at the following address:
Holiday Inn Washington-Chevy Chase,
5520 Wisconsin Ave, Chevy Chase, MD
20815, United States, telephone: 1 (301)
656–1500, fax: 1 (301) 656–5045.
Web site: You may access up-to-date
information on this meeting at https://
www.cms.hhs.gov/FACA/
10_mc.asp#TopOfPage.
FOR FURTHER INFORMATION CONTACT:
Margaret Reiser, (202) 205–8255.
SUPPLEMENTARY INFORMATION: On May
24, 2005, we published a notice (70 FR
29765) announcing the Medicaid
Commission and requesting
nominations for individuals to serve on
the Medicaid Commission. This notice
announces a public meeting of the
Medicaid Commission.
Topics of the Meeting
The Commission will discuss options
for making longer-term
recommendations on the future of the
Medicaid program that ensure long-term
sustainability. Issues to be addressed
may include, but are not limited to:
eligibility, benefit design, and delivery;
expanding the number of people
covered with quality care while
recognizing budget constraints; long
term care; quality of care, choice, and
beneficiary satisfaction; and program
administration.
Procedure and Agenda
This meeting is open to the public.
There will be a public comment period
at the meeting. The Commission may
limit the number and duration of oral
presentations to the time available. We
will request that you declare at the
meeting whether or not you have any
financial involvement related to any
services being discussed.
After the presentations and public
comment period, the Commission will
deliberate openly. Interested persons
may observe the deliberations, but the
Commission will not hear further
comments during this time except at the
request of the Chairperson. The
Commission will also allow an open
public session for any attendee to
address issues specific to the topic.
Authority: 5 U.S.C. App. 2, section 10(a)(1)
and (a)(2).
Dated: December 20, 2005.
Donald A.Young,
Acting Assistant Secretary for Planning and
Evaluation, Department of Health and
Human Services.
[FR Doc. E5–8097 Filed 12–29–05; 8:45 am]
BILLING CODE 5150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–06–05AD]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–4766 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Helping to End Lead Poisoning
(HELP): A Questionnaire Study of
Medicaid Providers’ Self-Reported
Attitudes, Practices, Beliefs, and
Barriers to Childhood Blood Lead
Testing—New—National Center for
Environmental Health, Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
According to the United States
Department of Health and Human
Services (DHHS), lead poisoning is one
of the most serious environmental
threats to children in the United States.
Very high blood lead levels in children
can cause encephalopathy, coma, and
even death. At lower levels, lead
poisoning is a silent attacker because
most children who are lead poisoned do
not show symptoms. Low levels of lead
poisoning are often associated with
reductions in IQ and attention span, and
with learning disabilities, hyperactivity,
and behavioral problems. Because of
these subtle effects, the best way to
determine if a child has lead poisoning
is by giving the child a blood lead test.
Children eligible for Medicaid are
typically at highest risk for lead
exposure. DHHS policies require blood
lead testing for all children participating
in Federal health care programs.
However, most children in or targeted
by Federal health care programs have
not been tested.
Although blood lead testing is
important, it is ineffective unless it is
performed when the child is young
enough to receive the full benefits of
effective environmental interventions.
Thus, it was determined by the CDC
Lead Poisoning Prevention Branch
(LPPB) that more information is needed
to understand the barriers Medicaid
providers face when it comes to blood
lead testing.
Helping To End Lead Poisoning
(HELP) is a comparison study between
two communities in Wisconsin. To
determine why some areas in Wisconsin
have high blood lead testing rates and
others do not, Medicaid providers in
two areas will be studied. Community 1
has high and Community 2 has low
blood lead testing rates. Questionnaires
will be mailed to all Medicaid providers
in these two Wisconsin communities.
The questionnaires will be sent from
and returned to the CDC LPPB in
Atlanta, Georgia. CDC will analyze the
data from the questionnaires. CDC and
the Wisconsin Childhood Lead
Poisoning Prevention Program staff will
use this information to understand the
barriers Medicaid providers face
concerning blood lead testing and to
develop effective strategies that promote
blood lead testing among Medicaid
providers. There is no cost to
respondents, other than their time.
National Center for Environment
Health (NCEH), is requesting a year to
complete the study. The total estimated
burden hours are 14.
ESTIMATED ANNUALIZED BURDEN HOURS
No. of
respondents
wwhite on PROD1PC61 with NOTICES
Respondents
Targeted Medicaid Providers in Wisconsin .................................................................................
(mailed questionnaire)
Targeted Medicaid Providers in Wisconsin .................................................................................
(telephone follow-up): ‘‘Yes’’
VerDate Aug<31>2005
18:16 Dec 29, 2005
Jkt 208001
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
E:\FR\FM\30DEN1.SGM
No. of
responses per
respondent
Average
burden per
response
(in hours)
13
1
10/60
60
1
10/60
30DEN1
77397
Federal Register / Vol. 70, No. 250 / Friday, December 30, 2005 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
No. of
respondents
Respondents
Targeted Medicaid Providers in Wisconsin .................................................................................
(telephone follow-up): ‘‘No’’ or mailed.
Dated: December 23, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E5–8098 Filed 12–29–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–06–05AZ]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–4766 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
NCEH/ATSDR Exposure
Investigations (EIs)—New—National
Center for Environmental Health
(NCEH) and the Agency for Toxic
Substances and Disease Registry
(ATSDR), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
This is a brief summary of a joint
clearance between the NCEH and
ATSDR, (hereafter ATSDR will
represent both ATSDR and NCEH).
ATSDR is mandated pursuant to the
1980 Comprehensive Environmental
No. of
responses per
respondent
49
1
Average
burden per
response
(in hours)
2/60
with results interpretation. General
information can account for
approximately 28 questions per
investigation. Some of this information
is investigation-specific; not all of this
data is collected for every investigation.
ATSDR is seeking approval for a set of
57 potential general information
questions.
ATSDR also collects information on
other possible confounding sources of
chemical(s) exposure such as medicines
taken, foods eaten, etc. In addition,
ATSDR asks questions on recreational
or occupational activities that could
increase exposure potential. This
information represents an individual’s
exposure history. To cover these broad
categories, ATSDR is also seeking
approval for the use of sets of topical
questions. Of these, ATSDR will use
approximately 12–15 questions about
the pertinent environmental exposures
per investigation. This number can vary
depending on the number of chemicals
being investigated, the route of exposure
(breathing, eating, touching), and
number of other sources (e.g., products,
jobs) for the chemical(s).
Typically, the number of participants
in an individual EI ranges from 10 to
less than 50. Questionnaires are
generally needed in less than half of the
EIs (approximately 10–15 per year).
Areas for the complete set of topical
questions include the following:
(1) Media specific which includes: air
(indoor/outdoor); water (water source
and plumbing); soil, and food
(gardening, fish, game, domestic
animals).
(2) Other sources such as: occupation;
hobbies; household uses or house
construction; lifestyle (e.g., smoking);
medicines and/or health conditions, and
foods.
There are no costs to the respondents
other than their time. The estimated
total burden hours are 375.
Response, Compensation, and Liability
Act (CERCLA) and its 1986
Amendments, the Superfund
Amendments and Reauthorization Act
(SARA) to prevent or mitigate adverse
human health effects and diminished
quality of life resulting from the
exposure to hazardous substances in the
environment. Exposure Investigations
(EIs) is an approach developed by
ATSDR that employs targeted biologic
(e.g., urine, blood, hair samples) and
environmental (e.g., air, water, soil, or
food) sampling to determine whether
people are or have been exposed to
unusual levels of pollutants at specific
locations (e.g., where people live, spend
leisure time, or anywhere they might
come into contact with contaminants
under investigation). After a chemical
release or suspected release into the
environment, ATSDR’s EIs are used by
public health professionals,
environmental risk managers, and other
decision makers to determine if current
conditions warrant intervention
strategies to minimize or eliminate
human exposure. EIs are usually
requested by officials of a state health
agency, county health departments, the
Environmental Protection Agency, the
general public, and ATSDR staff.
All of ATSDR’s biomedical
assessments and some of the
environmental investigations involve
participants. Participation is completely
voluntary. To assist in interpreting the
sampling results, a survey questionnaire
appropriate to the specific contaminant
will be administered to participants.
ATSDR collects contact information
(e.g., name, address, phone number) to
provide the participant with their
individual results. Name and address
information are broken into nine
separate questions (data fields) for
computer entry. General information,
which includes height, weight, age,
race, gender, etc., is needed primarily
on biomedical investigations to assist
wwhite on PROD1PC61 with NOTICES
ESTIMATE OF ANNUALIZED BURDEN TABLE
No. of
respondents
Respondents per response
Exposure Investigation Participants ............................................................................................
VerDate Aug<31>2005
18:16 Dec 29, 2005
Jkt 208001
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
E:\FR\FM\30DEN1.SGM
750
30DEN1
Responses
per
respondent
Average
burden
1
30/60
Agencies
[Federal Register Volume 70, Number 250 (Friday, December 30, 2005)]
[Notices]
[Pages 77396-77397]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-8098]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-06-05AD]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-4766 or send an email to
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
Helping to End Lead Poisoning (HELP): A Questionnaire Study of
Medicaid Providers' Self-Reported Attitudes, Practices, Beliefs, and
Barriers to Childhood Blood Lead Testing--New--National Center for
Environmental Health, Centers for Disease Control and Prevention (CDC).
Background and Brief Description
According to the United States Department of Health and Human
Services (DHHS), lead poisoning is one of the most serious
environmental threats to children in the United States. Very high blood
lead levels in children can cause encephalopathy, coma, and even death.
At lower levels, lead poisoning is a silent attacker because most
children who are lead poisoned do not show symptoms. Low levels of lead
poisoning are often associated with reductions in IQ and attention
span, and with learning disabilities, hyperactivity, and behavioral
problems. Because of these subtle effects, the best way to determine if
a child has lead poisoning is by giving the child a blood lead test.
Children eligible for Medicaid are typically at highest risk for
lead exposure. DHHS policies require blood lead testing for all
children participating in Federal health care programs. However, most
children in or targeted by Federal health care programs have not been
tested.
Although blood lead testing is important, it is ineffective unless
it is performed when the child is young enough to receive the full
benefits of effective environmental interventions. Thus, it was
determined by the CDC Lead Poisoning Prevention Branch (LPPB) that more
information is needed to understand the barriers Medicaid providers
face when it comes to blood lead testing.
Helping To End Lead Poisoning (HELP) is a comparison study between
two communities in Wisconsin. To determine why some areas in Wisconsin
have high blood lead testing rates and others do not, Medicaid
providers in two areas will be studied. Community 1 has high and
Community 2 has low blood lead testing rates. Questionnaires will be
mailed to all Medicaid providers in these two Wisconsin communities.
The questionnaires will be sent from and returned to the CDC LPPB in
Atlanta, Georgia. CDC will analyze the data from the questionnaires.
CDC and the Wisconsin Childhood Lead Poisoning Prevention Program staff
will use this information to understand the barriers Medicaid providers
face concerning blood lead testing and to develop effective strategies
that promote blood lead testing among Medicaid providers. There is no
cost to respondents, other than their time.
National Center for Environment Health (NCEH), is requesting a year
to complete the study. The total estimated burden hours are 14.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
No. of No. of burden per
Respondents respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Targeted Medicaid Providers in Wisconsin........................ 13 1 10/60
(mailed questionnaire)
Targeted Medicaid Providers in Wisconsin........................ 60 1 10/60
(telephone follow-up): ``Yes''
[[Page 77397]]
Targeted Medicaid Providers in Wisconsin........................ 49 1 2/60
(telephone follow-up): ``No'' or mailed.
----------------------------------------------------------------------------------------------------------------
Dated: December 23, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E5-8098 Filed 12-29-05; 8:45 am]
BILLING CODE 4163-18-P